Issue Information ‐ Editorial Board
Issue Information ‐ TOC1
Issue Information ‐ TOC2
Issue Information ‐ Papers to be published in forthcoming issues
Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders
Blood film findings in anaplasmosis
The cytological features of CAR(T) cells
Advances in understanding prognosis in myeloma
Alternatives to allogeneic platelet transfusion
Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome
Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2) : prolonged remissions without survival plateau
Application of an NGS‐based 28‐gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera
Epigenetic landscape of the TERT promoter : a potential biomarker for high risk AML/MDS
Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
Elotuzumab in combination with thalidomide and low‐dose dexamethasone : a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma
The phenotype and clinical course of Japanese Fanconi Anaemia infants is influenced by patient, but not maternal ALDH2 genotype
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study
Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B‐Cell Lymphoma treated with the AIEOP LNH‐97 protocol
Whole‐exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia
Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3‐ITD acute myeloid leukaemia in first complete remission
Recombinant IL‐7/HGFβ hybrid cytokine separates acute graft‐versus‐host‐disease from graft‐versus‐tumour activity by altering donor T cell trafficking
Endocytosis of exogenous factor V by ex‐vivo differentiated megakaryocytes from patients with severe parahaemophilia
ASH1L (a histone methyltransferase protein) is a novel candidate globin gene regulator revealed by genetic study of an English family with beta‐thalassaemia unlinked to the beta‐globin locus
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high‐risk follicular lymphoma due to severe haematological and infectious toxicity
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
Are Myeloproliferative neoplasms a risk factor for Heparin‐Induced Thrombocytopenia?
Cell cycle, proliferation and apoptosis in erythroblasts cultured from patients with β‐thalassaemia major
A model of BCR‐FGFR1 driven human AML in immunocompromised mice